GENETIC TOXICOLOGY TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Key Developments

• In May 2021, Eurofins BioPharma Product Testing Columbia entered into a collaboration agreement with Plus Therapeutics, Inc. The agreement focuses on supporting Plus Therapeutics’ process development and analytical chemistry activities for the cGMP manufacturing of Rhenium NanoLiposome (RNL), which is their primary investigational asset for recurrent glioblastoma. Plus Therapeutics, Inc. is a clinical stage pharmaceutical company specializing in novel therapies for rare and challenging cancers.
• In June 2021, OECD, (Organisation for Economic Co-operation and Development) approved the world’s first toxicology testing strategy that eliminates the need for animal testing. Developed by BASF and Givaudan, a global leading company in taste and wellbeing, and fragrance and beauty, it consists of three alternative methods to predict allergic reactions to skin without using animals.